Diabetes Clinical Trials in San Diego

Showing 481-500 of 515 trials

Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

NCT00143247

This is a long-term safety study for Phase 2 subjects who choose to remain on Exubera® (inhaled insulin).

Pfizer173 participantsStarted Mar 2003

San Diego, California, United States • New Haven, Connecticut, United States • Miami, Florida, United States +9 more locations

COMPLETEDPhase 26.9 miles

Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes

NCT00934414

Twelve smoking and twelve non-smoking subjects with Type 2 Diabetes Mellitus will be enrolled in this study to determine the effect of Technosphere® Insulin Inhalation Powder on insulin in the body during a clamp procedure.

Diabetes Type 2

Mannkind Corporation24 participantsStarted Aug 2004

Chula Vista, California, United States

UNKNOWNPhase 26.9 miles

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

NCT00482950

This study is to test the efficacy and safety of PHX1149T in combination with metformin, a glitazone, or metformin and a glitazone in subjects with Type 2 diabetes for 12 weeks. After completing the 12 week double blind part of the study, subjects can enter an open label extension study

Type 2 Diabetes Mellitus

Phenomix400 participantsStarted Apr 2007

Chula Vista, California, United States • Fullerton, California, United States • Long Beach, California, United States +23 more locations

Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

Diabetes Trials in Other Cities

To Evaluate the Response to Glucagon During Hypoglycemia

To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

Diabetes Control and Complications Trial (DCCT)

Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

Obese Patients With Type 2 Diabetes

Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.

Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to the American Diabetic Association (ADA) Diabetes Meal Plan on Body Weight and Satiety in Diabetic Women

Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus

Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System

Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

Other Conditions in San Diego